Literature DB >> 5643869

Plasma corticosteroid and growth hormone response to lysine-vasopressin in man.

J Brostoff, V H James, J Landon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5643869     DOI： 10.1210/jcem-28-4-511

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Ultrastructure and morphometry of ACTH-producing cell in the rat anterior pituitary gland stimulated by lysin-vasopressin and prostaglandin E1.

Authors:  J Caselitz; W Saeger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-05-05

2.  Adrenal cortical function in asthmatic children on alternate day steroids.

Authors:  J A Kuzemko; J G Lines
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

3.  [Steroid-induced adrenal gland hypofunction. Pathogenesis, clinical aspects, diagnosis, prevention and therapy].

Authors:  H Bethge
Journal:  Klin Wochenschr       Date:  1970-03-15

4.  Effect of corticotrophin therapy on pituitary-adrenal function.

Authors:  M E Carter; V H James
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

Review 5.  An attempt at combining corticotrophin with long-term corticosteroid therapy. With a view to preserving hypothalmic-pituitary-adrenal function.

Authors:  M E Carter; V H James
Journal:  Ann Rheum Dis       Date:  1970-07       Impact factor: 19.103

6.  Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man.

Authors:  J J Staub; J S Jenkins; J G Ratcliffe; J Landon
Journal:  Br Med J       Date:  1973-02-03

7.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.